Bismuth with dual therapy for H. pylori infection treatment
Part of Digestive system, Infections clinical trials.
This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have H. pylori infection confirmed by testing and have never been treated for it before
- You are at least 20 years old
- You are willing to take the study medications as prescribed for the full treatment period
- You are not pregnant, breastfeeding, or planning to become pregnant during the trial
- You do not have severe kidney disease, advanced liver disease, or active cancer
- You have not had your stomach surgically removed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination of medicines to treat H. pylori infection that has not gone away after at least two previous treatments. It may help if you have not had success with standard therapy and are looking for another option.
This study tests whether a 14-day treatment with bismuth and four drugs, chosen based on lab tests showing which antibiotics still work, can clear an extremely stubborn H. pylori infection that hasn't gone away after at least two prior treatments.
This trial tests whether a new type of acid-reducing drug (vonoprazan) works better than a common one (proton pump inhibitor) when combined with vitamin D or probiotics to clear H. pylori, a bacteria that can cause stomach problems. If you have H. pylori and haven't been treated for it before, this study may be for you.
This trial tests a 14-day treatment using two medicines, vonoprazan and minocycline, to get rid of an H. pylori infection in the stomach. It aims to see if this combination is safe and works well, and might be a simpler option for people who haven't been treated for H. pylori before.
This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.
This study tests a combination of a probiotic (Saccharomyces boulardii) plus a standard bismuth-based four-drug treatment for people whose H. pylori infection has not been cured by previous treatments. It aims to see if adding the probiotic helps the treatment work better and cause fewer side effects.
Hear when a new HELICOBACTER PYLORI INFECTIONS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.